Blog
Cultural Adaptation is Not an Option: International Research Benefits from Localization
Scientific research has become an increasingly globalized effort. As more countries prioritize their research funding, international clinical studies have become the norm. Localization of study tools, cultural awareness, and accurate translations have become crucial...
read moreTranslating Traditions: Holidays Around the World
Translation alone is often not enough to ensure an accurate message; cultural differences can make it easy to misunderstand the intended meaning of a text. For this reason, VeraSci insists that cultural adaptation and localization are not an option when it comes to...
read moreA Novel MS Patient-Centered Assessment to Monitor Symptomatology
Recent findings from a National Multiple Sclerosis (MS) Study estimate that nearly 1 million people in the US are living with MS, a number that has more than doubled since it was last reported in 1975. We at VeraSci are committed to helping our clients drive therapies...
read moreVeraSci Celebrates International Women’s Day Through Women Leadership and Diversity
March 8th was International Women’s Day, a day that we at VeraSci celebrate the work of a group of remarkable women – women scientists. While Marie Curie usually dominates the women in science conversation, there are many other brilliant women scientists. Not only did...
read moreDA4S West Coast Wrap Up
VeraSci attended the 6th Annual Diversity Alliance for Science West Coast Conference, February 20th-21st in Laguna Beach, California. VeraSci is honored to participate in one of the leading organizations in the life science and healthcare industries which promotes the...
read moreVeraSci Demonstrates the Sensitivity of a Tablet-Based Assessment of Visuospatial Working Memory
Clinical drug trials in preclinical AD populations require novel approaches to participant identification, screening, and enrollment. Execution of these trials requires rapid development of cognitive screening instruments that are straightforward, sensitive to...
read moreVeraSci Demonstrates Sensitivity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Subjective Cognitive Decline
Clinical trials in mild to moderate Alzheimer’s Disease (AD) rely on informant reports to characterize study participants’ performance on basic and instrumental activities of daily living. As clinical trials move earlier in the AD continuum, however, these...
read moreHoliday Language Blog Series – Part Three, Cultural Adaptation
Welcome to the third and final installment of our three-part blog series highlighting the importance of choosing the right language services partner. Cultural Adaptation and Localization Cultural adaptation and localization of clinical trial translations can be...
read moreHoliday Language Blog Series – Part Two, Interpretation
Welcome to the second installment of our three-part blog series highlighting the importance of choosing the right language services partner. Interpretation Interpretation goes beyond the word-for-word translation of a spoken or written message. Sentence...
read moreHoliday Language Blog Series – Part One, Translations
In the sharing spirit of the season, VeraSci is presenting a three-part blog series to use as a guide when selecting your language services partner. With the enormous investments and challenging timelines required for bringing new therapies to market, choosing the...
read more